In studies with genetically engineered mice, researchers say they have identified a potentially new biological target involving Aplp1, a cell surface protein that drives the spread of Parkinson's ...
Park is a senior health correspondent at TIME. She covers the COVID-19 pandemic, new drug developments in cancer and Alzheimer’s disease, mental health, HIV, CRISPR, and advances in gene therapy, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results